Ruthenium drug BOLD-100 regulates BRAFMT colorectal cancer cell apoptosis through AhR/ROS/ATR signaling axis modulation.

MLA

Griffin, Daryl, et al. “Ruthenium Drug BOLD-100 Regulates BRAFMT Colorectal Cancer Cell Apoptosis through AhR/ROS/ATR Signaling Axis Modulation.” Molecular Cancer Research : MCR, July 2024. EBSCOhost, https://doi.org/10.1158/1541-7786.MCR-24-0151.

APA

Griffin, D., Carson, R., Moss, D., Sessler, T., Lavin, D., Tiwari, V. K., Karelia, S., Kennedy, R., Savage, K. I., McDade, S., Carie, A., Pankovich, J., Bazett, M., & Van Schaeybroeck, S. (2024). Ruthenium drug BOLD-100 regulates BRAFMT colorectal cancer cell apoptosis through AhR/ROS/ATR signaling axis modulation. Molecular Cancer Research : MCR. https://doi.org/10.1158/1541-7786.MCR-24-0151

Chicago

Griffin, Daryl, Robbie Carson, Debbie Moss, Tamas Sessler, Deborah Lavin, Vijay K Tiwari, Shivaali Karelia, et al. 2024. “Ruthenium Drug BOLD-100 Regulates BRAFMT Colorectal Cancer Cell Apoptosis through AhR/ROS/ATR Signaling Axis Modulation.” Molecular Cancer Research : MCR, July. doi:10.1158/1541-7786.MCR-24-0151.